These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31399954)

  • 1. Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.
    Verma AK; Khan E; Bhagwat SR; Kumar A
    Mol Neurobiol; 2020 Jan; 57(1):566-584. PubMed ID: 31399954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triplet repeats in transcripts: structural insights into RNA toxicity.
    Galka-Marciniak P; Urbanek MO; Krzyzosiak WJ
    Biol Chem; 2012 Nov; 393(11):1299-315. PubMed ID: 23052488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interaction of DNA-Binding Ligands with Trinucleotide-Repeat DNA: Implications for Therapy and Diagnosis of Neurological Disorders.
    Chang CK; Jhan CR; Hou MH
    Curr Top Med Chem; 2015; 15(14):1398-408. PubMed ID: 25866276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Expanded Repeats by Small Molecules in Repeat Expansion Disorders.
    Nakamori M; Mochizuki H
    Mov Disord; 2021 Feb; 36(2):298-305. PubMed ID: 33284473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics studies of trinucleotide repeat DNA involved in neurodegenerative disorders.
    Jithesh PV; Singh P; Joshi R
    J Biomol Struct Dyn; 2001 Dec; 19(3):479-95. PubMed ID: 11790146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA structure of trinucleotide repeats associated with human neurological diseases.
    Sobczak K; de Mezer M; Michlewski G; Krol J; Krzyzosiak WJ
    Nucleic Acids Res; 2003 Oct; 31(19):5469-82. PubMed ID: 14500809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibilities and challenges of small molecule organic compounds for the treatment of repeat diseases.
    Nakatani K
    Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(1):30-48. PubMed ID: 35013029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular conformations and dynamics of nucleotide repeats associated with neurodegenerative diseases: double helices and CAG hairpin loops.
    Pan F; Zhang Y; Xu P; Man VH; Roland C; Weninger K; Sagui C
    Comput Struct Biotechnol J; 2021; 19():2819-2832. PubMed ID: 34093995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the immune system in triplet repeat expansion diseases.
    Olejniczak M; Urbanek MO; Krzyzosiak WJ
    Mediators Inflamm; 2015; 2015():873860. PubMed ID: 25873774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Ligand That Targets CUG Trinucleotide Repeats.
    Li J; Matsumoto J; Bai LP; Murata A; Dohno C; Nakatani K
    Chemistry; 2016 Oct; 22(42):14881-14889. PubMed ID: 27573860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.
    Martí E; Estivill X
    Front Mol Neurosci; 2013 Dec; 6():45. PubMed ID: 24348326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in CAG trinucleotide repeat expansion disorders: an integrated review of the literature.
    Dumitrescu L; Popescu BO
    CNS Neurol Disord Drug Targets; 2015; 14(2):176-93. PubMed ID: 25613508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trinucleotide repeats associated with human disease.
    Mitas M
    Nucleic Acids Res; 1997 Jun; 25(12):2245-54. PubMed ID: 9171073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target.
    Krzyzosiak WJ; Sobczak K; Wojciechowska M; Fiszer A; Mykowska A; Kozlowski P
    Nucleic Acids Res; 2012 Jan; 40(1):11-26. PubMed ID: 21908410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of trinucleotide-repeat RNA in neurological disease and degeneration.
    Li LB; Bonini NM
    Trends Neurosci; 2010 Jun; 33(6):292-8. PubMed ID: 20398949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA trinucleotide repeat expansion in neuropsychiatric patients.
    Mohmood S; Sherwani A; Khan F; Khan RH; Azfer A
    Med Sci Monit; 2003 Sep; 9(9):RA237-45. PubMed ID: 12960939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-associated repeat instability and mismatch repair.
    Schmidt MHM; Pearson CE
    DNA Repair (Amst); 2016 Feb; 38():117-126. PubMed ID: 26774442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of expansion of CAG or GAA repeats in schizophrenia families and monozygotic twins.
    Vincent JB; Kalsi G; Klempan T; Tatuch Y; Sherrington RP; Breschel T; McInnis MG; Brynjolfsson J; Petursson H; Gurling HM; Gottesman II; Torrey EF; Petronis A; Kennedy JL
    Hum Genet; 1998 Jul; 103(1):41-7. PubMed ID: 9737774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded CAG/CTG repeats resist gene silencing mediated by targeted epigenome editing.
    Yang B; Borgeaud AC; Buřičová M; Aeschbach L; Rodríguez-Lima O; Ruiz Buendía GA; Cinesi C; Taylor AS; Baubec T; Dion V
    Hum Mol Genet; 2022 Feb; 31(3):386-398. PubMed ID: 34494094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.